share_log

人福医药(600079.SH):收购子公司股权

Humanwell Healthcare (600079.SH): Acquires subsidiary's equity.

Gelonghui Finance ·  Jul 26 06:48

On July 26th, Gelonhui reported that Humanwell Healthcare (600079.SH) announced that in March 2022, the company acquired 40% of the equity in Hubei Gedian Humanwell Pharmaceutical Excipients Co., Ltd. (referred to as "Gedian Pharmaceutical Excipients"), a subsidiary of Wuhan Yaohua Pharmaceutical Co., Ltd. for RMB 100 million. After the completion of the transaction, the company and its holding subsidiary Hubei Gedian Humanwell Pharmaceutical Co., Ltd. (referred to as "Gedian Humanwell", which holds 81.07% of its equity) collectively hold 80% of the equity in Gedian Pharmaceutical Excipients. According to the notification letter received by the controlling shareholder, Wuhan Contemporary Technology Industry Group Co., Ltd. (referred to as "Contemporary Technology"), it was learned that its subsidiary could have a significant impact on Yaohua Pharmaceutical due to business relationships. Therefore, Yaohua Pharmaceutical is an associated party and this transaction constitutes a related-party transaction.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment